AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
GlaxoSmithKline (GSK) stock forecast for 2026
The forecast has been updated: November 30, 2022 14:08
GlaxoSmithKline stock price online today
Analyst Target Price
44.92Dividend Date
12.01.2023Ex Dividend Date
17.11.2022Last Split Factor
Last Split Date
01.01.1970Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $44.92 target price for GlaxoSmithKline stock stock.
Today 200 Day Moving Average is the resistance level (38.92 $).
50 Day Moving Average is the support level (31.57 $).
GSK Forecast for 2026
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 34.78 | 34.26 | 35.50 | 3.48 % |
| Mar | 34.25 | 33.53 | 34.57 | 3.01 % |
| Mar | 33.70 | 32.93 | 34.58 | 4.79 % |
| Apr | 33.06 | 32.49 | 33.69 | 3.56 % |
| May | 32.63 | 31.94 | 33.28 | 4.01 % |
| Jun | 33.00 | 32.34 | 33.81 | 4.34 % |
| Jul | 32.88 | 32.15 | 33.83 | 4.97 % |
| Aug | 33.44 | 32.50 | 34.17 | 4.89 % |
| Sep | 33.01 | 32.54 | 33.30 | 2.28 % |
| Oct | 32.99 | 32.05 | 33.71 | 4.92 % |
| Nov | 33.57 | 32.54 | 33.83 | 3.83 % |
| Dec | 34.13 | 33.60 | 35.01 | 4.03 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.
GlaxoSmithKline overview
GlaxoSmithKline Address
980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GBMarket Capitalization
70 345 335 000 $EBITDA
11 716 000 000PE Ratio
13.05PEG Ratio
1.078Dividend Per Share
0.762Dividend Yield
0.0552EPS
2.65Quarterly Earnings Growth YOY
7.77Quarterly Revenue Growth YOY
0.181Trailing PE
13.05Forward PE
9.4EV To Revenue
2.255EV To EBITDA
8.8452 Week High
46.4852 Week Low
28.1950 Day Moving Average
31.57200 Day Moving Average
38.92Shares Outstanding
2033690000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
GlaxoSmithKline stock forecast for this year
GlaxoSmithKline stock forecast for Jan 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 34.78. Positive monthly dynamics of the instrument is expected with 3.477% volatility is expected.
Pessimistic forecast: 34.26
Optimistic: 35.50
GlaxoSmithKline stock forecast for Mar 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 34.25. Negative monthly dynamics of the instrument is expected with 3.014% volatility is expected.
Pessimistic forecast: 33.53
Optimistic: 34.57
GlaxoSmithKline stock forecast for Mar 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 33.70. Negative monthly dynamics of the instrument is expected with 4.789% volatility is expected.
Pessimistic forecast: 32.93
Optimistic: 34.58
GlaxoSmithKline stock forecast for Apr 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 33.06. Negative monthly dynamics of the instrument is expected with 3.559% volatility is expected.
Pessimistic forecast: 32.49
Optimistic: 33.69
GlaxoSmithKline stock forecast for May 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 32.63. Negative monthly dynamics of the instrument is expected with 4.015% volatility is expected.
Pessimistic forecast: 31.94
Optimistic: 33.28
GlaxoSmithKline stock forecast for Jun 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 33.00. Positive monthly dynamics of the instrument is expected with 4.339% volatility is expected.
Pessimistic forecast: 32.34
Optimistic: 33.81
GlaxoSmithKline stock forecast for Jul 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 32.88. Negative monthly dynamics of the instrument is expected with 4.966% volatility is expected.
Pessimistic forecast: 32.15
Optimistic: 33.83
GlaxoSmithKline stock forecast for Aug 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 33.44. Positive monthly dynamics of the instrument is expected with 4.885% volatility is expected.
Pessimistic forecast: 32.50
Optimistic: 34.17
GlaxoSmithKline stock forecast for Sep 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 33.01. Negative monthly dynamics of the instrument is expected with 2.280% volatility is expected.
Pessimistic forecast: 32.54
Optimistic: 33.30
GlaxoSmithKline stock forecast for Oct 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 32.99. Negative monthly dynamics of the instrument is expected with 4.923% volatility is expected.
Pessimistic forecast: 32.05
Optimistic: 33.71
GlaxoSmithKline stock forecast for Nov 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 33.57. Positive monthly dynamics of the instrument is expected with 3.831% volatility is expected.
Pessimistic forecast: 32.54
Optimistic: 33.83
GlaxoSmithKline stock forecast for Dec 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 34.13. Positive monthly dynamics of the instrument is expected with 4.030% volatility is expected.
Pessimistic forecast: 33.60
Optimistic: 35.01
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 98.07 (04.11.2022) | 1.68 % |
 AbbVie Inc.
|
ABBV | 145.28 (04.11.2022) | 0.60 % |
 Aeterna Zentaris Inc.
|
AEZS | 4.01 (04.11.2022) | 2.82 % |
 Allakos Inc.
|
ALLK | 5.99 (04.11.2022) | 5.83 % |
 Allogene Therapeutics, Inc.
|
ALLO | 9.34 (04.11.2022) | -1.89 % |
 Amgen Inc.
|
AMGN | 269.04 (04.11.2022) | 1.19 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 4.75 (04.11.2022) | 2.15 % |
 Aurora Cannabis Inc.
|
ACB | 1.31 (04.11.2022) | -5.07 % |
 Becton Dickinson and Company
|
BDX | 220.84 (04.11.2022) | -0.07 % |
 Biogen Inc.
|
BIIB | 281.82 (04.11.2022) | 0.56 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 15.47 (04.11.2022) | 4.60 % |
 BioNTech SE
|
BNTX | 154.31 (04.11.2022) | 6.24 % |
 bluebird bio, Inc.
|
BLUE | 6.13 (04.11.2022) | -2.23 % |
 Boston Scientific Corp.
|
BSX | 41.59 (04.11.2022) | 0.14 % |
 Bristol-Myers Squibb Company
|
BMY | 78.78 (04.11.2022) | 0.38 % |
 Canopy Growth Corp.
|
CGC | 3.29 (04.11.2022) | -4.64 % |
 Castle Biosciences, Inc.
|
CSTL | 21.94 (04.11.2022) | -9.60 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
 Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 19.96 (04.11.2022) | 2.20 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 8.32 (04.11.2022) | 4.92 % |
 Gilead Sciences, Inc.
|
GILD | 80.34 (04.11.2022) | 1.11 % |
|
GlaxoSmithKline plc
|
GSK | 32.99 (04.11.2022) | 0.46 % |
 GoodRx Holdings, Inc.
|
GDRX | 5.06 (04.11.2022) | 3.27 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 77.3 (04.11.2022) | 0.52 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 2.11 (04.11.2022) | -1.40 % |
 Johnson & Johnson
|
JNJ | 171.48 (04.11.2022) | 0.45 % |
 Medtronic plc.
|
MDT | 84.65 (04.11.2022) | 0.75 % |
 Merck & Co., Inc.
|
MRK | 99.2 (04.11.2022) | 0.46 % |
 Moderna, Inc.
|
MRNA | 158.41 (04.11.2022) | 7.40 % |
 Novartis AG
|
NVS | 81.72 (04.11.2022) | 1.67 % |
 Novavax, Inc.
|
NVAX | 19.4 (04.11.2022) | -3.82 % |
 ObsEva SA
|
OBSV | 0.1688 (04.11.2022) | 0.60 % |
 OrganiGram Holdings Inc.
|
OGI | 0.9738 (04.11.2022) | 0.11 % |
 Pfizer Inc.
|
PFE | 47.22 (04.11.2022) | 1.40 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 740.21 (04.11.2022) | 0.21 % |
 Sanofi
|
SNY | 43.62 (04.11.2022) | 1.82 % |
 Schrodinger, Inc.
|
SDGR | 20.92 (04.11.2022) | -15.17 % |
 Senseonics Holdings, Inc.
|
SENS | 1.18 (04.11.2022) | -0.84 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 1.46 (04.11.2022) | -1.35 % |
 Stryker Corp.
|
SYK | 210.98 (04.11.2022) | 2.66 % |
 Sundial Growers Inc.
|
SNDL | 2.32 (04.11.2022) | -2.52 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.47 (04.11.2022) | -1.63 % |
 Thermo Fisher Scientific Inc.
|
TMO | 495.55 (04.11.2022) | 1.77 % |
 Tilray, Inc.
|
TLRY | 3.81 (04.11.2022) | -0.26 % |
 UnitedHealth Group, Inc.
|
UNH | 538.17 (04.11.2022) | -1.00 % |
 Veeva Systems Inc.
|
VEEV | 166.81 (04.11.2022) | -0.20 % |
|
Zomedica Corp.
|
ZOM | 0.2245 (04.11.2022) | -2.01 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 0.7051 (04.11.2022) | -2.07 % |
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.